These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
280 results:

  • 1. A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues.
    de Back TR; Wu T; Schafrat PJ; Ten Hoorn S; Tan M; He L; van Hooff SR; Koster J; Nijman LE; Vink GR; Beumer IJ; Elbers CC; Lenos KJ; Sommeijer DW; Wang X; Vermeulen L
    Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38782602
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Selective but not pan-CDK inhibition abrogates 5-FU-driven tissue factor upregulation in colon cancer.
    Kayser A; Wolff A; Berlin P; Duehring L; Henze L; Mundkowski R; Bergmann W; Müller-Hilke B; Wagner C; Huehns M; Oehmcke-Hecht S; Maletzki C
    Sci Rep; 2024 May; 14(1):10582. PubMed ID: 38719932
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines.
    Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z
    Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.
    Tassone P; Di Martino MT; Arbitrio M; Fiorillo L; Staropoli N; Ciliberto D; Cordua A; Scionti F; Bertucci B; Salvino A; Lopreiato M; Thunarf F; Cuomo O; Zito MC; De Fina MR; Brescia A; Gualtieri S; Riillo C; Manti F; Caracciolo D; Barbieri V; Di Paola ED; Di Francesco AE; Tagliaferri P
    J Hematol Oncol; 2023 Jun; 16(1):68. PubMed ID: 37365583
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Opportunities for Achieving the cancer Moonshot Goal of a 50% Reduction in cancer Mortality by 2047.
    Shiels MS; Lipkowitz S; Campos NG; Schiffman M; Schiller JT; Freedman ND; Berrington de González A
    Cancer Discov; 2023 May; 13(5):1084-1099. PubMed ID: 37067240
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular profiling of colorectal cancer in a genetically admixed Hispanic population.
    Montes-Rodríguez IM; Centeno-Girona H; Rivera-Lynch C; Rivera N; Cruz-Correa M
    Cancer Med; 2023 May; 12(10):11686-11702. PubMed ID: 37039257
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study.
    Maleux G; Albrecht T; Arnold D; Bargellini I; Cianni R; Helmberger T; Kolligs F; Munneke G; Peynircioglu B; Sangro B; Schaefer N; Pereira H; Zeka B; de Jong N; Bilbao JI;
    Cardiovasc Intervent Radiol; 2023 Jul; 46(7):852-867. PubMed ID: 36914788
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Crosstalk between protein kinase C α and transforming growth factor β signaling mediated by Runx2 in intestinal epithelial cells.
    Li X; Kaur N; Albahrani M; Karpf AR; Black AR; Black JD
    J Biol Chem; 2023 Apr; 299(4):103017. PubMed ID: 36791912
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Examination of colorectal cancer cases with metal allergy.
    Mizukoshi K; Okazawa Y; Amemiya K; Tsuchiya Y; Motegi S; Tsukamoto R; Honjo K; Takahashi R; Yoshihara N; Kawano S; Kawai M; Munakata S; Ishiyama S; Sugimoto K; Takahashi M; Kojima Y; Ikeda S; Sakamoto K
    Surg Today; 2023 Jul; 53(7):753-761. PubMed ID: 36757618
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. EMERGENCY SURGERY FOR OBSTRUCTING COLON cancer: MORBIDITY AND RISK FACTORS OF EARLY POSTOPERATIVE MORTALITY - A COHORT STUDY OF 118 CASES.
    Zaafouri H; Cherif M; Khedhiri N; Mesbahi M; Zebda H; Jouini R; Bellali H; Ben Maamer A
    Arq Bras Cir Dig; 2023; 35():e1706. PubMed ID: 36629687
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer.
    Qu X; Tan H; Mao J; Yang M; Xu J; Yan X; Wu W
    Cancer Med; 2023 Mar; 12(5):5926-5938. PubMed ID: 36281556
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. AD80, a multikinase inhibitor, as a potential drug candidate for colorectal cancer therapy.
    de Almeida LC; Carlos JAEG; Rezende-Teixeira P; Machado-Neto JA; Costa-Lotufo LV
    Life Sci; 2022 Nov; 308():120911. PubMed ID: 36030982
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immunohistochemical determination of mismatch repair gene product in colorectal carcinomas in a young indigenous African cohort.
    Holla R; Vorster A; Locketz M; De Haas M; Oke OA; Govender D; Ramesar R; Goldberg PA
    S Afr J Surg; 2022 Mar; 60(1):28-33. PubMed ID: 35451266
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effect of Sodium Butyrate on p16INK4a, p14ARF, p15INK4b, Class I HDACs (HDACs 1, 2, 3) Class II HDACs (HDACs 4, 5, 6), Cell Growth Inhibition and Apoptosis Induction in Pancreatic cancer AsPC-1 and Colon cancer HCT-116 Cell Lines.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2022 Mar; 23(3):795-802. PubMed ID: 35345349
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Detection of Colonic Polyps During Colonoscopy in a Tertiary Care Center of Nepal.
    Koirala D; Pathak R; Kafle Bhandari B; Jha A; Hamal R; Gnawali A; Pandey R; Bhusal M
    J Nepal Health Res Counc; 2021 Dec; 19(3):596-602. PubMed ID: 35140437
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Functional assessment of miR‑1291 in colon cancer cells.
    Wang J; Yokoyama Y; Hirose H; Shimomura Y; Bonkobara S; Itakura H; Kouda S; Morimoto Y; Minami K; Takahashi H; Shibata S; Kobayashi S; Uemura M; Tanaka S; Wu X; Tanaka S; Mori M; Yamamoto H
    Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 34981812
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. p27kip1 expression and phosphorylation dictate Palbociclib sensitivity in KRAS-mutated colorectal cancer.
    Rampioni Vinciguerra GL; Dall'Acqua A; Segatto I; Mattevi MC; Russo F; Favero A; Cirombella R; Mungo G; Viotto D; Karimbayli J; Pesce M; Vecchione A; Belletti B; Baldassarre G
    Cell Death Dis; 2021 Oct; 12(10):951. PubMed ID: 34654798
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. RAS specific protease induces irreversible growth arrest via p27 in several KRAS mutant colorectal cancer cell lines.
    Stubbs CK; Biancucci M; Vidimar V; Satchell KJF
    Sci Rep; 2021 Sep; 11(1):17925. PubMed ID: 34504197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?
    Dolina J; Kunovsky L; Kroupa R; Stary K; Jabandziev P; Nesporova T; Maca K; Andrasina T; Marek F; Kala Z; Vaculova J; Said D; Zapletalova M; Lochman J; Palova Noskova H; Slaby O; Izakovicova Holla L; Borilova Linhartova P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):228-235. PubMed ID: 34282806
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population.
    Bailey JA; Ibrahim H; Bunce J; Chapman CJ; Morling JR; Simpson JA; Humes DJ; Banerjea A
    Tech Coloproctol; 2021 Oct; 25(10):1151-1154. PubMed ID: 34263362
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.